These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 19000993

  • 1. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.
    Batuca JR, Ames PR, Amaral M, Favas C, Isenberg DA, Delgado Alves J.
    Rheumatology (Oxford); 2009 Jan; 48(1):26-31. PubMed ID: 19000993
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA.
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [Abstract] [Full Text] [Related]

  • 3. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Kumar S, Isenberg DA.
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [Abstract] [Full Text] [Related]

  • 4. Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus.
    Batuca JR, Ames PR, Isenberg DA, Alves JD.
    Ann N Y Acad Sci; 2007 Jun; 1108():137-46. PubMed ID: 17893980
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [Abstract] [Full Text] [Related]

  • 6. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M, Vignola S, Barbano G, Sormani MP, Sabatini F, Buoncompagni A, Picco P, Pistoia V.
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [Abstract] [Full Text] [Related]

  • 8. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T, Fierz W, Stoll T, Villiger PM.
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [Abstract] [Full Text] [Related]

  • 9. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 10. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB, Giles IP, Rahman A.
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [Abstract] [Full Text] [Related]

  • 11. Antibodies against HDL Components in Ischaemic Stroke and Coronary Artery Disease.
    Batuca JR, Amaral MC, Favas C, Justino GC, Papoila AL, Ames PRJ, Alves JD.
    Thromb Haemost; 2018 Jun; 118(6):1088-1100. PubMed ID: 29723873
    [Abstract] [Full Text] [Related]

  • 12. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
    Tso TK, Huang WN.
    J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
    [Abstract] [Full Text] [Related]

  • 13. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR, Matsuura E, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Alves JD.
    Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
    [Abstract] [Full Text] [Related]

  • 14. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y.
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [Abstract] [Full Text] [Related]

  • 15. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
    Montiel JL, Monsiváis-Urenda A, Figueroa-Vega N, Moctezuma JF, Burgos-Vargas R, González-Amaro R, Rosenstein Y.
    Scand J Rheumatol; 2010 Jun; 39(1):50-7. PubMed ID: 20132071
    [Abstract] [Full Text] [Related]

  • 17. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T, Ogawa F, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [Abstract] [Full Text] [Related]

  • 18. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus.
    Constans J, Dupuy R, Blann AD, Resplandy F, Seigneur M, Renard M, Longy-Boursier M, Schaeverbeke T, Guérin V, Boisseau MR, Conri C.
    J Rheumatol; 2003 Sep; 30(9):1963-6. PubMed ID: 12966599
    [Abstract] [Full Text] [Related]

  • 19. Natural antibodies against phosphorylcholine as potential protective factors in SLE.
    Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frostegård J.
    Rheumatology (Oxford); 2008 Aug; 47(8):1144-50. PubMed ID: 18522961
    [Abstract] [Full Text] [Related]

  • 20. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA, Elbasyouni SR, Kalil AM, Abdel-Rahim M, Mohsen T, Sleem A.
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.